SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001804220-20-000009
Filing Date
2020-05-05
Accepted
2020-05-05 07:35:20
Documents
16
Period of Report
2020-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-kq12020.htm   iXBRL 8-K 40145
2 EXHIBIT 99.1 exhibit991q12020.htm EX-99.1 416267
8 image0a12.jpg GRAPHIC 7835
  Complete submission text file 0001804220-20-000009.txt   640707

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT regn-20200505.xsd EX-101.SCH 4434
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT regn-20200505_cal.xml EX-101.CAL 610
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT regn-20200505_def.xml EX-101.DEF 1460
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT regn-20200505_lab.xml EX-101.LAB 26147
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT regn-20200505_pre.xml EX-101.PRE 13566
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-kq12020_htm.xml XML 4399
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19034 | Film No.: 20846858
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences